Which predicts the cardiovascular risk best in elderly metabolic syndrome patients: ATP III or IDF?


AYDIN S., Gemalmaz A., Nayir T., Ozkan S.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.41, ss.125-129, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 41 Konu: 1
  • Basım Tarihi: 2011
  • Doi Numarası: 10.3906/sag-0912-496
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Sayfa Sayıları: ss.125-129

Özet

Aim: As metabolic syndrome (MetS) is one of the major determinants of cardiovascular disease, it is important to detect and intervene with MetS in order to minimize cardiovascular risk. The objectives of this study were to identify the prevalence of MetS in our elderly patients and to evaluate the ability IDF and ATP III to predict the cardiovascular risk.